ATE247962T1 - Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung - Google Patents

Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung

Info

Publication number
ATE247962T1
ATE247962T1 AT96924896T AT96924896T ATE247962T1 AT E247962 T1 ATE247962 T1 AT E247962T1 AT 96924896 T AT96924896 T AT 96924896T AT 96924896 T AT96924896 T AT 96924896T AT E247962 T1 ATE247962 T1 AT E247962T1
Authority
AT
Austria
Prior art keywords
compositions containing
aqueous compositions
production
containing ciprofloxacin
ciprofloxacine
Prior art date
Application number
AT96924896T
Other languages
English (en)
Inventor
Soler Pedro Canovas
Duarte Joaquin Delgadillo
Rueda Juan Moreno
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Application granted granted Critical
Publication of ATE247962T1 publication Critical patent/ATE247962T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT96924896T 1995-08-03 1996-07-26 Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung ATE247962T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501578A ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
PCT/ES1996/000155 WO1997005880A1 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes

Publications (1)

Publication Number Publication Date
ATE247962T1 true ATE247962T1 (de) 2003-09-15

Family

ID=8291281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924896T ATE247962T1 (de) 1995-08-03 1996-07-26 Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung

Country Status (12)

Country Link
US (1) US5786363A (de)
EP (1) EP0806206B1 (de)
JP (1) JP4081521B2 (de)
AT (1) ATE247962T1 (de)
AU (1) AU701697B2 (de)
CA (1) CA2200760C (de)
DE (1) DE69629664T2 (de)
DK (1) DK0806206T3 (de)
ES (2) ES2106680B1 (de)
PT (1) PT806206E (de)
RU (1) RU2165755C2 (de)
WO (1) WO1997005880A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090B1 (es) * 2000-03-16 2002-07-01 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
JP5839189B2 (ja) * 2008-07-21 2016-01-06 オトノミ—,インク. 耳の不調の治療用の制御放出性の抗菌性組成物および方法
ES2391721T3 (es) 2010-03-01 2012-11-29 Laboratorios Salvat, S.A. Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
EP3512513A4 (de) 2016-09-16 2020-04-15 Otonomy, Inc. Gelformulierungen für das ohr zur behandlung von otitis externa
CN112986468B (zh) * 2019-12-13 2024-05-03 武汉九州钰民医药科技有限公司 检测盐酸环丙沙星片中氯代环丙沙星的分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
ATE162081T1 (de) * 1991-09-17 1998-01-15 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
JPH11500740A (ja) 1999-01-19
DE69629664T2 (de) 2004-06-24
AU701697B2 (en) 1999-02-04
ES2205048T3 (es) 2004-05-01
ES2106680B1 (es) 1998-07-01
EP0806206B1 (de) 2003-08-27
DK0806206T3 (da) 2003-12-08
JP4081521B2 (ja) 2008-04-30
EP0806206A1 (de) 1997-11-12
US5786363A (en) 1998-07-28
DE69629664D1 (de) 2003-10-02
PT806206E (pt) 2004-01-30
RU2165755C2 (ru) 2001-04-27
ES2106680A1 (es) 1997-11-01
CA2200760C (en) 2007-09-11
CA2200760A1 (en) 1997-02-20
AU6520196A (en) 1997-03-05
WO1997005880A1 (es) 1997-02-20

Similar Documents

Publication Publication Date Title
DE69312503D1 (de) Antimikrobielle zusammensetzung und verfahren zu ihrer herstellung
DE69329795D1 (de) Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
DE69207429D1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE89561T1 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
DE3668621D1 (de) Verfahren zur herstellung von pteridinderivaten.
ATE247962T1 (de) Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung
DE3866072D1 (de) Pestizide biosynthetische produkte enthaltende zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung.
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
ATE194014T1 (de) Verfahren zur reinigung von teppichen
DE69423402D1 (de) Stabile, pharmazeutische Zusammensetzungen die hybrid alpha-Interferon enthalten
ATE130845T1 (de) Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten.
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
DE3777743D1 (de) Verfahren zur herstellung von 1,4-diazabicyclo(2,2,2)-octanen.
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
ATE84780T1 (de) Neue di(meth)acrylate, verfahren zu deren herstellung und deren verwendung.
DE59914749D1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
ATE204582T1 (de) Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen
ATE176669T1 (de) Pteridin-derivate, verfahren zu ihrer herstellung sowie deren verwendung zur herstellung von immunogenen
DE3764330D1 (de) 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate.
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
DE59106994D1 (de) Verfahren zur reinigung von 7-chlor-chinolin-8-carbonsäuren.
ATE32063T1 (de) Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung.
ATE145642T1 (de) Verfahren zur herstellung von 1,3-dialkyl-5- hydroxyoxindolen und deren etherderivaten

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0806206

Country of ref document: EP

EEIH Change in the person of patent owner
EEIH Change in the person of patent owner